The board of directors of Perrigo Co. plc has unanimously rejected Mylan N.V.’s unsolicited bid to buy the company. Perrigo said late Tuesday that Mylan’s $205-per-share offer earlier this month, a deal estimated at about $29 billion, undervalues the company and its growth prospects.
Market Performance Group (MPG) announced that founding partner Tim Toohey is retiring and that the company has named two new members to its advisory board.
Coca-Cola and CVS/pharmacy are among the participants in the Fit Family Challenge, a healthy living initiative launched in North Carolina. Coca-Cola Bottling Co. Consolidated said that North Carolina Gov.
Efficient Collaborative Retail Marketing (ECRM) has acquired PressCamp, a media meet manufacturer event business focused on the cycling industry, from Lifeboat Events LLC. Financial terms of the agreement weren’t disclosed.
Teva Pharmaceutical Industries Ltd. has made a bid to acquire Mylan N.V. in a cash-and-stock deal valued at about $40 billion.
AZO has added to its line of women’s health products with the rollout of AZO Cranberry Gummies. The i-Health Inc. brand said Monday that AZO Cranberry Gummies are made with Pacran, a super-concentrated cranberry powder that helps flush the urinary tract to maintain cleanliness.
Generic drug company Leading Pharma LLC has entered a multiyear development pact with specialty research-and-development company Carnegie Pharmaceuticals LLC.
Consumer goods executive Elio Leoni Sceti is joining Coty Inc. as chief executive officer. Sceti, 49, comes to Coty from European frozen food company Iglo Group, where he served as CEO since May 2013. He takes over from Bart Becht, interim CEO and chairman at Coty. Coty said Monday that Sceti is
Discount Drug Mart is slated to begin carrying Bikini Ready Lifestyle and SlimTrim dietary supplement products from Inergetics Inc. Inergetics said Bikini Ready Lifestyle and SlimTrim are due to hit shelves at Discount Drug Mart’s 72 stores in Ohio this month.
Aurobindo Pharma Ltd. has received the first Abbreviated New Drug Application approval from the Food and Drug Administration for cefixime for oral suspension, USP, 100 mg/5 ml and 200 mg/5 ml. Cefixime for O.S. is bioequivalent and therapeutically equivalent to Suprax from Lupin Pharmaceuticals Inc.
John Castellani, president and chief executive officer of Pharmaceutical Research and Manufacturers of America (PhRMA), plans to retire next year. PhRMA said Thursday that Castellani’s retirement is slated to go into effect Jan. 1, 2016.
Sandoz has received Food and Drug Administration approval for Glatopa, a treatment for multiple sclerosis (MS). The Novartis subsidiary said Thursday that its product is the first generic version of Teva’s Copaxone (glatiramer acetate injection) 20 mg/ml once-daily MS therapy.
NBTY Inc. has appointed four senior executives to its management team, who will be charged with spearheading growth initiatives for the nutritional supplement maker and marketer’s branded businesses. NBTY said Thursday that Andre Branch has joined the company as chief marketing officer.
Medline Industries Inc. has formed an integrated electronic purchasing partnership with Brightree, a provider of cloud-based clinical, business management and billing software solutions for the post-acute care industry.
NovaBay Pharmaceuticals Inc, a maker of nonantibiotic, anti-infective products for eye care and wound care, has signed a national distribution pact with AmerisourceBergen Corp.
Ramona Sequeira has been appointed president of Takeda Pharmaceuticals U.S.A. Inc., a unit of Takeda Pharmaceutical Co. The company said this week that Sequeira will lead all business operations for the United States and report to Christophe Weber, president and chief executive officer of Takeda.
